Sousa MV, Garza SB, Llamosa CL

Language: Spanish
References: 24
Page: 17-21
PDF size: 428.50 Kb.

ABSTRACT

The aim of the present case report was to evaluate the clinical achievements when a combination of autogenous bone graft and enamel matrix derivative (EMD) is applied in degree II maxilar and mandibular furcation involvements. Seven vestibular degree II furcation involvements were included. The degree of involvement was assessed prior to surgery and seven months later by radiographs and clinical attachment levels. At seven months the clinical parameters improved. The results suggest that the application of autogenous bone graft and enamel matrix derivative in the treatment of degree II maxilar and mandibular furcation involvements may result in gain of clinical attachment levels and osseous filling. Nevertheless, histological and controlled clinical trials are needed to determine the real clinical significance of these results.

REFERENCES

1. Sculean A, Windisch P, Chiantella GC. Human histologic evaluation of an intrabony defect treated with enamel matrix derivative, xenograft, and GTR. Int J Periodontics Restorative Dent 2004; 24 (4): 326-33.

2. Donos N, Glavind L, Karring T, Sculean A. Clinical evaluation of an enamel matrix derivative in the treatment of mandibular degree II furcation involvement: a 36-month case series. Int J Periodontics Restorative Dent 2003; 23 (5): 507-12.

3. Froum S, Weinberg M, Novak J, Mailhot J, Mellonig J, Van Dyke T, McClain P, Papapanou PN, Childers G, Ciancio S, Blieden T, Polson A, Greenstein G, Yukna R, Wallace ML, Patters M, Wagener C. A multicenter study evaluating the sensitization potential of enamel matrix derivative after treatment of two infrabony defects. J Periodontol. 2004; 75 (7): 1001-8.

4. Pontoriero R, Lindhe J, Nyman S, Karring T, Rosenberg E, Sanavi F. Guided tissue regeneration in degree II furcation-involved mandibular molars. A clinical study. J Clin Periodontol 1988; 15 (4): 247-54.

5. Yukna CN, Yukna RA. Multi-center evaluation of bioabsorbable collagen membrane for guided tissue regeneration in human Class II furcations. J Periodontol 1996; 67 (7): 650-7.

6. Hürzeler MB, Quiñones CR, Caffesse RG, Schüpbach P, Morrison EC. Guided periodontal tissue regeneration in Class II furcation defects following treatment with a synthetic bioabsorbable barrier. J Periodontol 1997; 68 (5): 498-505.

7. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev. 20097; (4):CD003875. Review.

8. Cattaneo V, Rota C, Silvestri M, Piacentini C, Forlino A, Gallanti A, Rasperini G, Cetta G. Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study. J Periodontal Res 2003; 38 (6): 568-74.

9. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997; 24 (9 Pt 2): 658-68. Review.

10. Cochran DL, Jones A, Heijl L, Mellonig JT, Schoolfield J, King GN. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting. J Periodontol 2003; 74 (9): 1269-81.

11. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 2001; 72 (1): 25-34.

12. Heijl L, Heden G, Svärdström G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997; 24 (9 Pt 2): 705-14.

13. Keats AS. The ASA classification of physical status-a recapitulation. Anesthesiology 1978; 49 (4): 233-6.

14. Armitage GC, Research, Science and Therapy Committee of the American Academy of Periodontology. Diagnosis of periodontal diseases. J Periodontol 2003; 74 (8): 1237-47.

15. Kwok V, Caton JG. Commentary: prognosis revisited: a system for assigning periodontal prognosis. J Periodontol 2007; 78 (11): 2063-71.

16. Matuliene G, Studer R, Lang NP, Schmidlin K, Pjetursson BE, Salvi GE, Brägger U, Zwahlen M. Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss. J Clin Periodontol 2010; 37 (2): 191-9.

17. Hoang T, Jorgensen MG, Keim RG, Pattison AM, Slots J. Povidone-iodine as a periodontal pocket disinfectant. J Periodontal Res 2003; 38 (3): 311-7.

18. Herrera D, Alonso B, León R, Roldán S, Sanz M. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 2008; 35 (8 Suppl): 45-66. Review.

19. Fastlicht J. Adult orthodontics. J Clin Orthod 1982;16 (9): 606-18.

20. Artun J, Urbye KS. The effect of orthodontic treatment on periodontal bone support in patients with advanced loss of marginal periodontium. Am J Orthod Dentofacial Orthop 1988; 93 (2): 143-8.

21. Segelnick SL, Weinberg MA. Reevaluation of initial therapy: when is the appropriate time? J Periodontol 2006; 77 (9): 1598-601.

22. Davies R, Scully C, Preston AJ. Dentifrices-an update. Med Oral Patol Oral Cir Bucal 2010; 15 (6): e976-82.

23. Donnenfeld OW. Therapeutic end-points in periodontal therapy. Int J Periodontics Restorative Dent 1981; 1 (4): 50-9.

24. Cortellini P, Pini-Prato G, Tonetti M. Periodontal regeneration of human infrabony defects (V). Effect of oral hygiene on long-term stability. J Clin Periodontol 1994; 21 (9): 606-10.